Home » Stocks » AMGN

Amgen Inc. (AMGN)

Stock Price: $258.60 USD 1.50 (0.58%)
Updated Jan 26, 2021 4:00 PM EST - Market closed
Market Cap 150.55B
Revenue (ttm) 24.99B
Net Income (ttm) 7.35B
Shares Out 585.00M
EPS (ttm) 12.40
PE Ratio 20.86
Forward PE 13.77
Dividend $7.04
Dividend Yield 2.72%
Trading Day January 26
Last Price $258.60
Previous Close $257.10
Change ($) 1.50
Change (%) 0.58%
Day's Open 256.59
Day's Range 254.86 - 259.07
Day's Volume 2,006,822
52-Week Range 178.60 - 259.07

News

Hide News
  • All
  • Videos
  • Press Releases
  • Conversation
Zacks Investment Research - 2 hours ago

Amgen (AMGN) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Seeking Alpha - 2 days ago

Two new breakout stocks for Week 4 of 2021 with better than 10% short-term upside potential. This past week 3 out of 4 stocks gained over 10% in a short trading week but gave back most of thei...

Other stocks mentioned: AAPL, DIS, DOW, HD, JNJ, MRK, NKE, NVR, QDEL, TRV, VSTO
GuruFocus - 3 days ago

"It's far better to buy a wonderful company at a fair price than a fair company at a wonderful price," Warren Buffett (Trades, Portfolio) famously said in his 1989 letter to the shareholders o...

Other stocks mentioned: JCOM, LAD
Zacks Investment Research - 6 days ago

Amgen (AMGN) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.

InvestorPlace - 6 days ago

Politics is a wildcard that can negatively impact healthcare stocks. But there are still many top companies with great prospects to consider.

Other stocks mentioned: CERN, MRK, PFE, SYK, UNH, XLV
Seeking Alpha - 1 week ago

Amgen sales are not reliant on any one product. Dividend growth has been exceptional but will moderate a bit going forward.

Seeking Alpha - 1 week ago

The Dow Jones Industrial Average (DIA) index has lagged significantly behind other flagship large cap indices over the past several years. DIA and Dow Jones Transportation index broke out to f...

Other stocks mentioned: BA, CRM, DIA, GS, HD, HON, IYT, MCD, MSFT, QQQ, SPY, UNH, V, XLF, XLI
Forbes - 1 week ago

The Dogs of the Dow is a venerable strategy. But some dogs are better than others.

Other stocks mentioned: CSCO, DOW, IBM, KO, MRK, VZ, VZA, WBA
Seeking Alpha - 1 week ago

Merck and Amgen are major pharmaceuticals that experienced slowing sales in the mid 2010s due to patent expirations and biosimilar competition. However, Merck recently experienced strong botto...

Other stocks mentioned: GILD, LLY, MRK
Seeking Alpha - 1 week ago

Week 3 MDA Breakout Stocks - January 2021: Short-Term Picks To Give You An Edge

Other stocks mentioned: AAPL, CAT, DIS, DOW, JNJ, JPM, LPTH, MAA, MRK, NKE, NVR, VBIV
The Motley Fool - 1 week ago

Hint: Apple didn't even come close to making the list.

Other stocks mentioned: CRM, GS, HD, UNH
The Motley Fool - 1 week ago

Buy these three biotech stocks before they take off.

Other stocks mentioned: ILMN, TRIL
Seeking Alpha - 2 weeks ago

Data indicates The Dogs of the Dow outperform over long time frames. I contend the Dogs provide a good risk/reward profile for Dividend Growth investors.

Other stocks mentioned: CSCO, CVX, DOW, IBM, KO, MMM, MSFT, TSLA, VDE, WBA
Seeking Alpha - 2 weeks ago

Amgen Inc. (AMGN) CEO Robert Bradway Presents at 39th Annual JPMorgan Virtual Healthcare Conference (Transcript)

PRNewsWire - 2 weeks ago

THOUSAND OAKS, Calif., Jan. 11, 2021 /PRNewswire/ -- Amgen (NASDAQ: AMGN) today announced the launch of a new seven-year environmental sustainability plan, which includes a commitment to achie...

InvestorPlace - 2 weeks ago

Here are seven cheap stocks with solid businesses that may power portfolios in 2021 The post The 7 Best Cheap Stocks to Kick Off 2021 appeared first on InvestorPlace. More From InvestorPlace W...

Other stocks mentioned: DHI, FDX, GM, JPM, PRU, WBA
Business Wire - 2 weeks ago

MENLO PARK, Calif.--(BUSINESS WIRE)--GRAIL, Inc., a healthcare company whose mission is to detect cancer early, today announced collaborations with global biopharmaceutical companies Amgen (NA...

Other stocks mentioned: AZN, BMY
Forbes - 2 weeks ago

For income investors, dividend strategies don't come any easier than the “Dogs of the Dow.”

Other stocks mentioned: CSCO, CVX, DOW, IBM, KO, MMM, MRK, VZ, WBA
Bloomberg Markets and Finance - 2 weeks ago

Amgen CEO Bradway on Vaccine Rollout, New Products

Jan.07 -- Amgen Inc. Chairman and Chief Executive Officer Robert Bradway discusses the development and rollout of coronavirus therapies and vaccines, the impact of the Covid-19 pandemic on med...

Benzinga - 2 weeks ago

Moderna Inc (NASDAQ: MRNA), which received the fourth regulatory nod for its investigational coronavirus vaccine with the conditional approval granted Wednesday by the European Union, is leavi...

Other stocks mentioned: MRNA
Market Watch - 2 weeks ago

Shares of Moderna Inc. were down 0.2% in trading on Thursday after the company said it had hired an Amgen executive to run commercial operations as it rolls out the first doses of its COVID-19...

Other stocks mentioned: MRNA
The Motley Fool - 2 weeks ago

This not-so-old strategy of identifying undervalued blue chip stocks has had its moments -- but not enough of them.

Other stocks mentioned: CSCO, CVX, DOW, IBM, KO, MMM, MRK, PFE, VZ, WBA, XOM
PRNewsWire - 2 weeks ago

THOUSAND OAKS, Calif., Jan. 6, 2021 /PRNewswire/ -- Amgen (NASDAQ:AMGN) will present at the 39th Annual J.P. Morgan Healthcare Conference at 11:50 a.m. PT on Monday, Jan. 11, 2021. Robert A. B...

Kiplinger - 2 weeks ago

The Dogs of the Dow were flea-bitten last year, but this simple dividend-investing strategy will try to return to greatness in 2021.

Other stocks mentioned: CSCO, CVX, DOW, IBM, KO, MMM, MRK, VZ, VZA, WBA
The Motley Fool - 3 weeks ago

Here are the newest stocks to join the portfolio for those using this easy-to-follow strategy.

Other stocks mentioned: BA, CRM, CSCO, CVX, DOW, IBM, KO, MMM, MRK, PFE, VZ, WBA, XOM
The Motley Fool - 3 weeks ago

If you're worried about another market crash, don't pass up these three unstoppable healthcare stocks.

Other stocks mentioned: PFE, TDOC
24/7 Wall Street - 3 weeks ago

In the 10 days since we posted our preliminary list of 2021's Dogs of the Dow, more than 23,000 Americans have died from causes related to the COVID-19 pandemic.

Other stocks mentioned: CSCO, CVX, DIA, DOW, IBM, KO, MMM, MRK, VZ, WBA
The Motley Fool - 4 weeks ago

Dividends are only part of the story for these two high-yielders.

Other stocks mentioned: JPM
Seeking Alpha - 1 month ago

Amgen has seen strong revenue and earnings growth, as supported by its strong stable of drugs. It also has a fast-growing biosimilar practice, and a promising pipeline.

Seeking Alpha - 1 month ago

In my monthly series of 10 Dividend Growth Stocks, I rank a selection of dividend growth stocks in Dividend Radar and present the 10 top-ranked stocks for consideration. To rank stocks, I use ...

Other stocks mentioned: ATO, BMY, CSCO, GD, LMT, MMM, MRK, PFE, PNW
Zacks Investment Research - 1 month ago

Amgen (AMGN) and AstraZeneca (AZN) plan to file regulatory applications for tezepelumab next year.

Other stocks mentioned: AZN
Zacks Investment Research - 1 month ago

The regulatory filing for Amgen's (AMGN) sotorasib is based on data from a phase II study, which shows that sotorasib led to durable anticancer activity in advanced NSCLC patients with KRAS G1...

PRNewsWire - 1 month ago

THOUSAND OAKS, Calif. and MELBOURNE, Australia, Dec. 22, 2020 /PRNewswire/ -- Amgen (NASDAQ:AMGN) and Medicines Development for Global Health (MDGH), a non-profit biopharmaceutical company, to...

24/7 Wall Street - 1 month ago

Perhaps no year since World War II will be less missed than 2020. The coronavirus pandemic has claimed more than 1.7 million lives so far this year.

Other stocks mentioned: CSCO, CVX, DOW, IBM, KO, MMM, MRK, VZ, WBA
PRNewsWire - 1 month ago

THOUSAND OAKS, Calif., Dec. 21, 2020 /PRNewswire/ -- Amgen (NASDAQ:AMGN) and AstraZeneca today announced the SOURCE trial did not meet the primary endpoint of a statistically significant reduc...

Seeking Alpha - 1 month ago

This weekly article series covers dividend changes. A summary table provides relevant data and key statistics of dividend increases.

Other stocks mentioned: ABM, ACU, BCPC, BEN, CHCO, ENSG, LLY, WASH
The Motley Fool - 1 month ago

In terms of its payouts to shareholders, drugmaker Amgen has better stats than the tech powerhouse.

Barrons - 1 month ago

Dividend increases, which were very rare early in the pandemic as plenty of firms cut or suspended their payouts, have become more frequent as 2020 has gone along.

Other stocks mentioned: LLY, BEN, DRI
GuruFocus - 1 month ago

This is an exciting time for dividend growth investors as it seems companies of all sizes and industries are announcing dividend increases. We will highlight three large companies that have pr...

Other stocks mentioned: AVGO, LLY
PRNewsWire - 1 month ago

CAMBRIDGE, Mass., Dec. 17, 2020 /PRNewswire/ -- Amgen (NASDAQ: AMGN) and LabCentral today announced that Octagon Therapeutics and Seranova Bio have each won an Amgen Golden Ticket to LabCentra...

PRNewsWire - 1 month ago

THOUSAND OAKS, Calif., Dec. 17, 2020 /PRNewswire/ -- Amgen (NASDAQ:AMGN) today announced that the U.S. Food and Drug Administration (FDA) has approved RIABNI™ (rituximab-arrx), a biosimilar to...

Zacks Investment Research - 1 month ago

The NDA filing for Amgen's (AMGN) sotorasib is based on data from a phase II study, which showed that sotorasib led to durable anticancer activity in advanced NSCLC patients with KRAS G12C mut...

The Motley Fool - 1 month ago

And their dividend payments could continue to climb higher.

Other stocks mentioned: HD, V
PRNewsWire - 1 month ago

THOUSAND OAKS, Calif., Dec. 16, 2020 /PRNewswire/ -- Amgen Inc. (NASDAQ: AMGN) today announced its intention to transfer the securities exchange listing for its 1.250% Senior Notes due 2022 an...

PRNewsWire - 1 month ago

THOUSAND OAKS, Calif., Dec. 16, 2020 /PRNewswire/ -- Amgen (NASDAQ:AMGN) today announced that its Board of Directors declared a $1.76 per share dividend for the first quarter of 2021. The divi...

PRNewsWire - 1 month ago

THOUSAND OAKS, Calif., Dec. 16, 2020 /PRNewswire/ -- Amgen (NASDAQ:AMGN) today announced submission of a New Drug Application (NDA) to the U.S. Food and Drug Administration (FDA) for sotorasib...

Seeking Alpha - 1 month ago

I run my KISS Portfolio screen each month to look for buying opportunities. I present here the stocks that passed the KISS screen this month.

InvestorPlace - 1 month ago

For those who are put off by the extreme enthusiasm of this bull market, the usually reliable Dow Jones stocks offer much-needed balance. Here are seven to consider.

Other stocks mentioned: AAPL, HD, IBM, MMM, MSFT, WMT
Zacks Investment Research - 1 month ago

Amgen (AMGN) closed at $227.40 in the latest trading session, marking a -0.33% move from the prior day.

24/7 Wall Street - 1 month ago

The short interest data is out for November 30, the most recent settlement date. Generally speaking, companies within the biotech industry are considered a riskier group of stocks, with big po...

Other stocks mentioned: ALXN, BIIB, GILD, MRNA, REGN, VRTX

About AMGN

Amgen discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta, a pegylated protein to treat cancer patients; Prolia to treat postmenopausal women with osteoporosis; Xgeva for skeletal-related events prevention; Aranesp to treat a lower-than-normal number of red blood cells and anemia; ... [Read more...]

Industry
Drug Manufacturers-General
Founded
1980
CEO
Robert Bradway
Employees
23,400
Stock Exchange
NASDAQ
Ticker Symbol
AMGN
Full Company Profile

Financial Performance

In 2019, Amgen's revenue was $23.36 billion, a decrease of -1.62% compared to the previous year's $23.75 billion. Earnings were $7.84 billion, a decrease of -6.58%.

Financial Statements

Analyst Forecasts

According to 30 analysts, the average rating for Amgen stock is "Buy." The 12-month stock price forecast is 255.64, which is a decrease of -1.14% from the latest price.

Price Target
$255.64
(-1.14% downside)
Analyst Consensus: Buy